Immutep (IMMP) Asset Utilization Ratio (2017)

Immutep (IMMP) posted Asset Utilization Ratio of 0.09 for Q2 2017, down 99.76% on a QoQ basis from 37.13 in Q1 2017.

Immutep (IMMP) Asset Utilization Ratio (2017) Analysis & Trends

Immutep's Asset Utilization Ratio history runs 1 years deep, the most recent figure standing at 0.09 for Q2 2017.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.09 in Q2 2017, while the trailing twelve-month figure through Jun 2017 was 0.09 (changed N/A YoY) and the FY2025 annual result came in at 0.06, up 26.99% from the prior year.
Asset Utilization Ratio was 0.09 for Q2 2017 at Immutep, down from 37.13 in the prior quarter.
Across five years, Asset Utilization Ratio topped out at 37.13 in Q1 2017 and bottomed at 0.09 in Q2 2017.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	0.69
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	0.47
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	0.37
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Immutep	569.08 Mn	569.08 Mn	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2017	0.09
Mar 31, 2017	37.13